{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T16:57:55Z","timestamp":1715101075228},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00108-020-00930-w","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T13:26:56Z","timestamp":1610026016000},"page":"672-678","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bewusstseinsst\u00f6rung, Tachypnoe und Tachykardie bei einem 71-j\u00e4hrigen Patienten mit Diabetes mellitus Typ\u00a02"],"prefix":"10.1007","volume":"62","author":[{"given":"S.","family":"Gro\u00dfmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Girlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"issue":"1","key":"930_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/dom.13012","volume":"20","author":"BM Bonora","year":"2018","unstructured":"Bonora\u00a0BM, Avogaro\u00a0A, Fadini\u00a0GP (2018) Sodium-glucose co-transporter\u20112 inhibitors and diabetic ketoacidosis: an updated review of the literature. Diabetes Obes Metab 20(1):25\u201333","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"930_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12245-019-0240-0","volume":"12","author":"A Diaz-Ramos","year":"2019","unstructured":"Diaz-Ramos\u00a0A, Eilbert\u00a0W, Marquez\u00a0D (2019) Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter\u20112 inhibitor use: a\u00a0case report and review of the literature. Int J Emerg Med 12(1):27","journal-title":"Int J Emerg Med"},{"issue":"22","key":"930_CR3","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman\u00a0B et\u00a0al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N\u00a0Engl J Med 373(22):2117\u20132128","journal-title":"N Engl J Med"},{"issue":"21","key":"930_CR4","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray\u00a0JJV et\u00a0al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N\u00a0Engl J Med 381(21):1995\u20132008","journal-title":"N Engl J Med"},{"issue":"7","key":"930_CR5","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.2337\/dc16-0330","volume":"39","author":"E Ferrannini","year":"2016","unstructured":"Ferrannini\u00a0E, Mark\u00a0M, Mayoux\u00a0E (2016) CV protection in the EMPA-REG OUTCOME trial: a \u201cthrifty substrate\u201d hypothesis. Diabetes Care 39(7):1108\u20131114","journal-title":"Diabetes Care"},{"issue":"15","key":"930_CR6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer\u00a0M et\u00a0al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N\u00a0Engl J Med 383(15):1413\u20131424","journal-title":"N Engl J Med"},{"key":"930_CR7","volume-title":"Fachinformation Jardiance","author":"B Ingelheim","year":"2019","unstructured":"Ingelheim\u00a0B (2019) Fachinformation Jardiance (Rote Lise)"},{"issue":"7","key":"930_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2337\/dc09-9032","volume":"32","author":"AE Kitabchi","year":"2009","unstructured":"Kitabchi\u00a0AE et\u00a0al (2009) Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32(7):1335\u20131343","journal-title":"Diabetes Care"},{"issue":"5866","key":"930_CR9","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/bmj.2.5866.578","volume":"2","author":"JF Munro","year":"1973","unstructured":"Munro\u00a0JF et\u00a0al (1973) Euglycaemic diabetic ketoacidosis. Br Med\u00a0J 2(5866):578\u2013580","journal-title":"Br Med J"},{"issue":"1","key":"930_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4239\/wjd.v10.i1.16","volume":"10","author":"A Gallo de Moraes","year":"2019","unstructured":"Gallo de Moraes\u00a0A, Surani\u00a0S (2019) Effects of diabetic ketoacidosis in the respiratory system. World J Diabetes 10(1):16\u201322","journal-title":"World J Diabetes"},{"issue":"21","key":"930_CR11","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1055\/s-0042-109042","volume":"141","author":"M Kimmel","year":"2016","unstructured":"Kimmel\u00a0M, Alscher\u00a0MD (2016) Disorders of the acid-base balance and the anion gap. Dtsch Med Wochenschr 141(21):1549\u20131554","journal-title":"Dtsch Med Wochenschr"},{"issue":"9","key":"930_CR12","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1681\/ASN.2006121408","volume":"18","author":"A Rastegar","year":"2007","unstructured":"Rastegar\u00a0A (2007) Use of the DeltaAG\/DeltaHCO3\u2212 ratio in the diagnosis of mixed acid-base disorders. J\u00a0Am Soc Nephrol 18(9):2429\u20132431","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"930_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jcjd.2017.05.004","volume":"41","author":"S Dizon","year":"2017","unstructured":"Dizon\u00a0S et al (2017) Insights into the recognition and management of SGLT2-inhibitor-associated ketoacidosis: it\u2019s not just euglycemic diabetic ketoacidosis. Can J Diabetes 41(5):499\u2013503","journal-title":"Can J Diabetes"},{"issue":"4","key":"930_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2337\/cd16-0027","volume":"35","author":"S Shoukat","year":"2017","unstructured":"Shoukat\u00a0S et\u00a0al (2017) Euglycemic diabetic ketoacidosis accompanied by severe hypophosphatemia during recovery in a\u00a0patient with type 2 diabetes being treated with canagliflozin\/metformin combination therapy. Clin Diabetes 35(4):249\u2013251","journal-title":"Clin Diabetes"},{"issue":"10","key":"930_CR15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.amjmed.2005.02.014","volume":"118","author":"A Gaasbeek","year":"2005","unstructured":"Gaasbeek\u00a0A, Meinders\u00a0AE (2005) Hypophosphatemia: an update on its etiology and treatment. Am J Med 118(10):1094\u20131101","journal-title":"Am J Med"},{"issue":"2","key":"930_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.6065\/apem.2018.23.2.103","volume":"23","author":"HS Choi","year":"2018","unstructured":"Choi\u00a0HS et\u00a0al (2018) Respiratory failure in a\u00a0diabetic ketoacidosis patient with severe hypophosphatemia. Ann Pediatr Endocrinol Metab 23(2):103\u2013106","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"930_CR17","doi-asserted-by":"publisher","DOI":"10.4414\/smf.2019.08247","author":"F Pfefferkorn","year":"2019","unstructured":"Pfefferkorn\u00a0F et\u00a0al (2019) Diabetische Ketoazidose unter Empagliflozin. Swiss Med Forum. https:\/\/doi.org\/10.4414\/smf.2019.08247","journal-title":"Swiss Med Forum"},{"issue":"8","key":"930_CR18","doi-asserted-by":"publisher","first-page":"10.1002\/dmrr.29","DOI":"10.1002\/dmrr.2924","volume":"33","author":"JE Blau","year":"2017","unstructured":"Blau\u00a0JE et\u00a0al (2017) Ketoacidosis associated with SGLT2 inhibitor treatment: analysis of FAERS data. Diabetes Metab Res Rev 33(8):10.1002\/dmrr.2924. https:\/\/doi.org\/10.1002\/dmrr.2924","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"930_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3803\/EnM.2018.33.2.147","volume":"33","author":"P Pozzilli","year":"2018","unstructured":"Pozzilli\u00a0P, Pieralice\u00a0S (2018) Latent autoimmune diabetes in adults: current status and new horizons. Endocrinol Metab (Seoul) 33(2):147\u2013159","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"9","key":"930_CR20","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2337\/dc15-0843","volume":"38","author":"AL Peters","year":"2015","unstructured":"Peters\u00a0AL et al (2015) Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care 38(9):1687\u20131693","journal-title":"Diabetes Care"},{"issue":"9","key":"930_CR21","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.2337\/dc15-1251","volume":"38","author":"N Erondu","year":"2015","unstructured":"Erondu\u00a0N et\u00a0al (2015) Diabetic ketoacidosis and related events in the canagliflozin type 2 diabetes clinical program. Diabetes Care 38(9):1680\u20131686","journal-title":"Diabetes Care"},{"issue":"23","key":"930_CR22","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1056\/NEJMc1701990","volume":"376","author":"M Fralick","year":"2017","unstructured":"Fralick\u00a0M, Schneeweiss\u00a0S, Patorno\u00a0E (2017) Risk of diabetic ketoacidosis after initiation of an SGLT2 inhibitor. N\u00a0Engl J Med 376(23):2300\u20132302","journal-title":"N Engl J Med"},{"key":"930_CR23","doi-asserted-by":"publisher","first-page":"k4365","DOI":"10.1136\/bmj.k4365","volume":"363","author":"P Ueda","year":"2018","unstructured":"Ueda\u00a0P et\u00a0al (2018) Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ 363:k4365","journal-title":"BMJ"},{"issue":"12","key":"930_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.15585\/mmwr.mm6712a3","volume":"67","author":"SR Benoit","year":"2018","unstructured":"Benoit\u00a0SR et al (2018) Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality\u2014United States, 2000\u20132014. Mmwr Morb Mortal Wkly Rep 67(12):362\u2013365","journal-title":"Mmwr Morb Mortal Wkly Rep"},{"issue":"S01","key":"930_CR25","first-page":"S40","volume":"15","author":"T Haak","year":"2020","unstructured":"Haak\u00a0T et al (2020) Therapie des Typ-1-Diabetes \u2013 Kurzfassung der S3 Leitlinie (AWMF-registernummer: 057-013; 2.\u00a0Auflage). Diabetol Stoffwechs 15(S01):S40\u2013S50","journal-title":"Diabetol Stoffwechs"},{"issue":"6","key":"930_CR26","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.ajem.2010.02.004","volume":"29","author":"SA Mahler","year":"2011","unstructured":"Mahler\u00a0SA et\u00a0al (2011) Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis. Am J Emerg Med 29(6):670\u2013674","journal-title":"Am J Emerg Med"},{"issue":"5","key":"930_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.diabet.2019.01.001","volume":"45","author":"JY Jeon","year":"2019","unstructured":"Jeon\u00a0JY et al (2019) Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors. Diabetes Metab 45(5):453\u2013457","journal-title":"Diabetes Metab"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-020-00930-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-020-00930-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-020-00930-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T08:02:57Z","timestamp":1624262577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-020-00930-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["930"],"URL":"https:\/\/doi.org\/10.1007\/s00108-020-00930-w","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"8 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Gro\u00dfmann, U.\u00a0Hoffmann und C.\u00a0Girlich geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}